At BigDNA, our aim is to develop effective and safe vaccines for human and veterinary use and we recognise that the most effective way to do this is through collaboration. We actively seek industry and academic partners who share a common vision with us and bring complementary strengths to our development programmes.
How we do this can be accomplished in a number of ways: through collaborative vaccine research and development, joint ventures or active licensing of our platform technology and products. BigDNA may also be interested in speaking with partners with complementary technologies and novel antigens.
To discuss opportunities in working with BigDNA, please contact:
Dr John March
Chief Executive Officer/Chief Scientific Officer
Tel. (+44) 131 200 6342
Email: care of Aileen.Waugh@bigdna.co.uk